Equities

Abliva AB

Abliva AB

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (SEK)0.3025
  • Today's Change0.018 / 6.14%
  • Shares traded11.63m
  • 1 Year change-40.84%
  • Beta1.2348
Data delayed at least 15 minutes, as of Feb 03 2023 17:00 GMT.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • ABLI:STO price moved over +2.07% to 0.32

Key statistics

On Friday, Abliva AB (ABLI:STO) closed at 0.3025, 91.46% above the 52 week low of 0.158 set on Oct 28, 2022.
52-week range
Today
0.158Oct 28 20220.5362Feb 04 2022
Markit short selling activity
Low
Med
High
Open0.2855
High0.3155
Low0.2855
Bid--
Offer--
Previous close0.3025
Average volume15.11m
Shares outstanding1.06bn
Free float973.98m
P/E (TTM)--
Market cap319.53m SEK
EPS (TTM)-0.2269
SEK
Data delayed at least 15 minutes, as of Feb 03 2023 17:00 GMT.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.